CLYM vs SYRE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 13, 2026

CLYM

31.0
AI Score
VS
SYRE Wins

SYRE

43.7
AI Score

Investment Advisor Scores

CLYM

31score
Recommendation
AVOID NEW MONEY

SYRE

44score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric CLYM SYRE Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% 0.0% Tie
Earnings Growth 0.0% -99.7% CLYM
Tradestie Score 31.0/100 43.7/100 SYRE
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY HOLD SYRE

Relative Price Performance (Last 90 Days)

CLYM 1M: -4.0% · 3M: -40.0% SYRE 1M: +28.3% · 3M: -1.7%

Current Technical Phase

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.3 · Price: $10.47

SYRE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 58

RSI (14): 58.1 · Price: $102.77

Fundamentals Snapshot

Metric CLYM SYRE
Market Cap — —
Forward P/E -10.4 -28.2
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — —
Operating Margin 0.0% 0.0%
EPS -0.81 -2.49
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, SYRE is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.